Macmillan RD - Search Results

1

The prognostic significance of B lymphocytes in invasive carcinoma of the breast.

Mahmoud SM, Lee AH, Paish EC, Macmillan RD, Ellis IO, Green AR. Mahmoud SM, et al. Among authors: macmillan rd. Breast Cancer Res Treat. 2012 Apr;132(2):545-53. doi: 10.1007/s10549-011-1620-1. Epub 2011 Jun 14. Breast Cancer Res Treat. 2012. PMID: 21671016

2

An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer.

Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Lee AH, Ellis IO, Green AR. Mahmoud SM, et al. Among authors: macmillan rd. Breast Cancer Res Treat. 2011 May;127(1):99-108. doi: 10.1007/s10549-010-0987-8. Epub 2010 Jun 17. Breast Cancer Res Treat. 2011. PMID: 20556505

3

MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups.

Aleskandarany MA, Rakha EA, Macmillan RD, Powe DG, Ellis IO, Green AR. Aleskandarany MA, et al. Among authors: macmillan rd. Breast Cancer Res Treat. 2011 Jun;127(3):591-9. doi: 10.1007/s10549-010-1028-3. Epub 2010 Jul 11. Breast Cancer Res Treat. 2011. PMID: 20623333

4

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AH, Ellis IO, Green AR. Mahmoud SM, et al. Among authors: macmillan rd. J Clin Oncol. 2011 May 20;29(15):1949-55. doi: 10.1200/JCO.2010.30.5037. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21483002

5

Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast.

Fernández B, Paish EC, Green AR, Lee AH, Macmillan RD, Ellis IO, Rakha EA. Fernández B, et al. Among authors: macmillan rd. J Clin Pathol. 2011 Nov;64(11):995-1000. doi: 10.1136/jclinpath-2011-200151. Epub 2011 Jun 28. J Clin Pathol. 2011. PMID: 21712309

6

EpCAM expression is an indicator of recurrence in basal-like breast cancer.

Agboola AJ, Paish EC, Rakha EA, Powe DG, Macmillan RD, Ellis IO, Green AR. Agboola AJ, et al. Among authors: macmillan rd. Breast Cancer Res Treat. 2012 Jun;133(2):575-82. doi: 10.1007/s10549-011-1813-7. Epub 2011 Oct 15. Breast Cancer Res Treat. 2012. PMID: 22002520

7

The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients.

Khoshnaw SM, Rakha EA, Abdel-Fatah T, Nolan CC, Hodi Z, Macmillan RD, Ellis IO, Green AR. Khoshnaw SM, et al. Among authors: macmillan rd. Breast Cancer Res Treat. 2013 Jan;137(1):139-53. doi: 10.1007/s10549-012-2358-0. Epub 2012 Dec 6. Breast Cancer Res Treat. 2013. PMID: 23225145

8

Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade?

Rakha EA, van Deurzen CH, Paish EC, Macmillan RD, Ellis IO, Lee AH. Rakha EA, et al. Among authors: macmillan rd. Mod Pathol. 2013 Apr;26(4):496-501. doi: 10.1038/modpathol.2012.197. Epub 2012 Dec 14. Mod Pathol. 2013. PMID: 23238630 Free article.

9

Biological and clinical significance of PARP1 protein expression in breast cancer.

Green AR, Caracappa D, Benhasouna AA, Alshareeda A, Nolan CC, Macmillan RD, Madhusudan S, Ellis IO, Rakha EA. Green AR, et al. Among authors: macmillan rd. Breast Cancer Res Treat. 2015 Jan;149(2):353-62. doi: 10.1007/s10549-014-3230-1. Epub 2014 Dec 21. Breast Cancer Res Treat. 2015. PMID: 25528020 Free PMC article.

10

DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.

Aleskandarany M, Caracappa D, Nolan CC, Macmillan RD, Ellis IO, Rakha EA, Green AR. Aleskandarany M, et al. Among authors: macmillan rd. Breast Cancer Res Treat. 2015 Feb;150(1):81-90. doi: 10.1007/s10549-015-3306-6. Epub 2015 Feb 19. Breast Cancer Res Treat. 2015. PMID: 25690937 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page